Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Usher III Initiative prepares novel compounds for Usher syndrome

Nov. 29, 2012

No Comments

Phase IIb trial of AM-111 in severe hearing loss meets primary endpoint

Nov. 15, 2012

No Comments

Recruitment complete in first stage of TACTT1 study

Aug. 14, 2012

No Comments

Auris Medical completes enrollment in AM-111 trial

April 24, 2012

No Comments

Study reveals new therapeutic use for phosphodiesterase 5 inhibitors

Feb. 24, 2012

No Comments

Pergamum begins phase II DPK-060 trial in outer ear infections

Jan. 17, 2012

No Comments

JNK inhibitor prevents hearing loss due to transient cochlear ischemia in preclinical study

Jan. 12, 2012

No Comments

Phage Pharmaceuticals submits IND for first-in-class therapeutic

Dec. 27, 2011

No Comments

Second milestone reached in GenVec/Novartis collaboration

Dec. 7, 2011

No Comments

Peptide P-13 ameliorates experimental otitis media

July 14, 2011

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ear, nose and throat
RSS

Usher III Initiative prepares novel compounds for Usher syndrome

Phase IIb trial of AM-111 in severe hearing loss meets primary endpoint

Recruitment complete in first stage of TACTT1 study

Auris Medical completes enrollment in AM-111 trial

Study reveals new therapeutic use for phosphodiesterase 5 inhibitors

Pergamum begins phase II DPK-060 trial in outer ear infections

JNK inhibitor prevents hearing loss due to transient cochlear ischemia in preclinical study

Phage Pharmaceuticals submits IND for first-in-class therapeutic

Second milestone reached in GenVec/Novartis collaboration

Peptide P-13 ameliorates experimental otitis media

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

‘Evo’ AI can design complete genomes

Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection

Ear, nose and throat RSS

Ear, nose and throat
RSS